ZIPRASIDONE MESYLATE
NDC 51662-1564, ZIPRASIDONE MESYLATE, injection, powder, lyophilized, for solution, from HF Acquisition Co LLC, DBA HealthFirst.
- Product NDC
- 51662-1564
- Status
- Listed
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211908
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1564 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZIPRASIDONE MESYLATE20 mg/mL
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51662-1564-3 | 51662156403 | 10 POUCH in 1 CASE (51662-1564-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1564-2) / 5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c75971f8-9640-a6e8-e053-2995a90af654Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=51662-1564
Use it
Look up 51662-1564 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1564 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51662-1564. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.